Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

365 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
MC1R variants increase risk of melanomas harboring BRAF mutations.
Fargnoli MC, Pike K, Pfeiffer RM, Tsang S, Rozenblum E, Munroe DJ, Golubeva Y, Calista D, Seidenari S, Massi D, Carli P, Bauer J, Elder DE, Bastian BC, Peris K, Landi MT. Fargnoli MC, et al. Among authors: landi mt. J Invest Dermatol. 2008 Oct;128(10):2485-90. doi: 10.1038/jid.2008.67. Epub 2008 Mar 27. J Invest Dermatol. 2008. PMID: 18368129 Free PMC article.
BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site.
Bauer J, Büttner P, Murali R, Okamoto I, Kolaitis NA, Landi MT, Scolyer RA, Bastian BC. Bauer J, et al. Among authors: landi mt. Pigment Cell Melanoma Res. 2011 Apr;24(2):345-51. doi: 10.1111/j.1755-148X.2011.00837.x. Pigment Cell Melanoma Res. 2011. PMID: 21324100 Free PMC article.
Familial melanoma aggregation in north-eastern Italy.
Calista D, Goldstein AM, Landi MT. Calista D, et al. Among authors: landi mt. J Invest Dermatol. 2000 Oct;115(4):764-5. doi: 10.1046/j.1523-1747.2000.00124-4.x. J Invest Dermatol. 2000. PMID: 10998160 Free article. No abstract available.
Blood DNA methylation, nevi number, and the risk of melanoma.
Pergoli L, Favero C, Pfeiffer RM, Tarantini L, Calista D, Cavalleri T, Angelici L, Consonni D, Bertazzi PA, Pesatori AC, Landi MT, Bollati V. Pergoli L, et al. Among authors: landi mt. Melanoma Res. 2014 Oct;24(5):480-7. doi: 10.1097/CMR.0000000000000112. Melanoma Res. 2014. PMID: 25026000 Free PMC article.
MC1R gene variants and non-melanoma skin cancer: a pooled-analysis from the M-SKIP project.
Tagliabue E, Fargnoli MC, Gandini S, Maisonneuve P, Liu F, Kayser M, Nijsten T, Han J, Kumar R, Gruis NA, Ferrucci L, Branicki W, Dwyer T, Blizzard L, Helsing P, Autier P, García-Borrón JC, Kanetsky PA, Landi MT, Little J, Newton-Bishop J, Sera F, Raimondi S; M-SKIP Study Group. Tagliabue E, et al. Among authors: landi mt. Br J Cancer. 2015 Jul 14;113(2):354-63. doi: 10.1038/bjc.2015.231. Epub 2015 Jun 23. Br J Cancer. 2015. PMID: 26103569 Free PMC article.
Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia.
Dalmasso B, Pastorino L, Nathan V, Shah NN, Palmer JM, Howlie M, Johansson PA, Freedman ND, Carter BD, Beane-Freeman L, Hicks B, Molven A, Helgadottir H, Sankar A, Tsao H, Stratigos AJ, Helsing P, Van Doorn R, Gruis NA, Visser M, Wadt KAW, Mann G, Holland EA, Nagore E, Potrony M, Puig S, Menin C, Peris K, Fargnoli MC, Calista D, Soufir N, Harland M, Bishop T, Kanetsky PA, Elder DE, Andreotti V, Vanni I, Bruno W, Höiom V, Tucker MA, Yang XR, Andresen PA, Adams DJ, Landi MT, Hayward NK, Goldstein AM, Ghiorzo P; GenoMEL; MelaNostrum consortia. Dalmasso B, et al. Among authors: landi mt. Genet Med. 2021 Nov;23(11):2087-2095. doi: 10.1038/s41436-021-01240-8. Epub 2021 Jul 14. Genet Med. 2021. PMID: 34262154 Free PMC article.
On combining family and case-control studies.
Pfeiffer RM, Pee D, Landi MT. Pfeiffer RM, et al. Among authors: landi mt. Genet Epidemiol. 2008 Nov;32(7):638-46. doi: 10.1002/gepi.20338. Genet Epidemiol. 2008. PMID: 18454494 Free PMC article.
MC1R variants in relation to naevi in melanoma cases and controls: a pooled analysis from the M-SKIP project.
Stefanaki I, Stratigos AJ, Kypreou KP, Evangelou E, Gandini S, Maisonneuve P, Polsky D, Lazovich D, Newton-Bishop J, Kanetsky PA, Puig S, Gruis NA, Ghiorzo P, Pellegrini C, De Nicolo A, Ribas G, Guida G, Garcia-Borron JC, Fargnoli MC, Nan H, Landi MT, Little J, Sera F, Raimondi S; M-SKIP Study Group. Stefanaki I, et al. Among authors: landi mt. J Eur Acad Dermatol Venereol. 2021 Feb;35(2):e135-e138. doi: 10.1111/jdv.16869. Epub 2020 Sep 6. J Eur Acad Dermatol Venereol. 2021. PMID: 32780924 Free PMC article. No abstract available.
Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.
Demenais F, Mohamdi H, Chaudru V, Goldstein AM, Newton Bishop JA, Bishop DT, Kanetsky PA, Hayward NK, Gillanders E, Elder DE, Avril MF, Azizi E, van Belle P, Bergman W, Bianchi-Scarrà G, Bressac-de Paillerets B, Calista D, Carrera C, Hansson J, Harland M, Hogg D, Höiom V, Holland EA, Ingvar C, Landi MT, Lang JM, Mackie RM, Mann GJ, Ming ME, Njauw CJ, Olsson H, Palmer J, Pastorino L, Puig S, Randerson-Moor J, Stark M, Tsao H, Tucker MA, van der Velden P, Yang XR, Gruis N; Melanoma Genetics Consortium. Demenais F, et al. Among authors: landi mt. J Natl Cancer Inst. 2010 Oct 20;102(20):1568-83. doi: 10.1093/jnci/djq363. Epub 2010 Sep 28. J Natl Cancer Inst. 2010. PMID: 20876876 Free PMC article.
365 results